RICHMAN ERIC I

Director at Lev Pharmaceuticals Inc · on record since Feb 16, 2007
Director at Altimmune, Inc. · on record since Jun 21, 2010
Director at ADMA BIOLOGICS, INC. · on record since Feb 15, 2012
President and CEO at Altimmune, Inc. · on record since Dec 15, 2014
Director at NeuBase Therapeutics, Inc. · on record since Jul 16, 2019
Director at Gain Therapeutics, Inc. · on record since Aug 17, 2021
Chief Executive Officer at Gain Therapeutics, Inc. · on record since Mar 17, 2021

Insider trading activity of RICHMAN ERIC I

Transactions on record: 114; since Feb 16, 2007

Open-market buys: 20; $336.3K

Open-market sells: 6; $750.5K

Companies traded: 5; last filing Jun 25, 2025

Figures computed from official regulatory filings — .

Companies where RICHMAN ERIC I has traded

Gain Therapeutics, Inc.12 tx · $102.8K · Jun 25, 2025
NeuBase Therapeutics, Inc.11 tx · $96.4K · Sep 12, 2022
ADMA BIOLOGICS, INC.18 tx · $113.8K · Mar 3, 2020
Altimmune, Inc.68 tx · $2.5M · Nov 23, 2016
Lev Pharmaceuticals Inc5 tx · Oct 21, 2008

Track record of RICHMAN ERIC I

Statistical track record

Free account

Open-market buys: 21

Last buy: Jul 1, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of RICHMAN ERIC I

Co-insiders of RICHMAN ERIC I

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Gain Therapeutics, Inc.Listing on record	Jun 25, 2025	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Jul 1, 2024	Buy	5,000	1.23 USD	$6.2K	conv 46First in 12mo	SEC
Gain Therapeutics, Inc.Listing on record	Jul 1, 2024	Buy	12,000	1.21 USD	$14.5K	conv 47First in 12mo	SEC
Gain Therapeutics, Inc.Listing on record	Jun 26, 2024	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Sep 22, 2023	Exercise	54,900	—	n/a (No price was disclosed in the filing)		SEC
Gain Therapeutics, Inc.Listing on record	Sep 22, 2023	ExerciseD (derivative)	-54,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Sep 22, 2022	AwardD (derivative)	329,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Sep 22, 2022	AwardD (derivative)	54,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeuBase Therapeutics, Inc.Listing unverified	Sep 12, 2022	AwardD (derivative)	37,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	May 27, 2022	Buy	2,482	2.58 USD	$6.4K	conv 32	SEC
Gain Therapeutics, Inc.Listing on record	May 23, 2022	Buy	9,256	2.83 USD	$26.2K	conv 38	SEC
Gain Therapeutics, Inc.Listing on record	May 23, 2022	Buy	4,000	2.71 USD	$10.8K	conv 35	SEC
Gain Therapeutics, Inc.Listing on record	Apr 21, 2022	Buy	4,922	7.87 USD	$38.7K	conv 46	SEC
NeuBase Therapeutics, Inc.Listing unverified	Mar 7, 2022	Buy	1,300	1.72 USD	$2.2K	conv 13	SEC
NeuBase Therapeutics, Inc.Listing unverified	Mar 7, 2022	Buy	1,000	1.62 USD	$1.6K	conv 13	SEC
NeuBase Therapeutics, Inc.Listing unverified	Mar 7, 2022	Buy	1,580	1.58 USD	$2.5K	conv 21	SEC
NeuBase Therapeutics, Inc.Listing unverified	Sep 17, 2021	AwardD (derivative)	38,135	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeuBase Therapeutics, Inc.Listing unverified	Apr 27, 2021	Buy	5,000	5.00 USD	$25K	conv 41Cluster	SEC
NeuBase Therapeutics, Inc.Listing unverified	Sep 11, 2020	AwardD (derivative)	14,634	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeuBase Therapeutics, Inc.Listing unverified	May 4, 2020	Buy	8,333	6.00 USD	$50K	conv 62ClusterFirst in 12mo	SEC
NeuBase Therapeutics, Inc.Listing unverified	May 4, 2020	Buy	2,500	6.00 USD	$15K	conv 40ClusterFirst in 12mo	SEC
ADMA BIOLOGICS, INC.Listing on record	Mar 3, 2020	Award	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADMA BIOLOGICS, INC.Listing on record	Mar 3, 2020	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeuBase Therapeutics, Inc.Listing unverified	Jul 16, 2019	Award	25,247	—	n/a (No price was disclosed in the filing)		SEC
NeuBase Therapeutics, Inc.Listing unverified	Jul 16, 2019	AwardD (derivative)	227,330	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Gain Therapeutics, Inc.Listing on record	Jun 25, 2025	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Jul 1, 2024	Buy	5,000	1.23 USD	$6.2K	conv 46First in 12mo	SEC
Gain Therapeutics, Inc.Listing on record	Jul 1, 2024	Buy	12,000	1.21 USD	$14.5K	conv 47First in 12mo	SEC
Gain Therapeutics, Inc.Listing on record	Jun 26, 2024	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Sep 22, 2023	Exercise	54,900	—	n/a (No price was disclosed in the filing)		SEC
Gain Therapeutics, Inc.Listing on record	Sep 22, 2023	ExerciseD (derivative)	-54,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Sep 22, 2022	AwardD (derivative)	329,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	Sep 22, 2022	AwardD (derivative)	54,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeuBase Therapeutics, Inc.Listing unverified	Sep 12, 2022	AwardD (derivative)	37,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Gain Therapeutics, Inc.Listing on record	May 27, 2022	Buy	2,482	2.58 USD	$6.4K	conv 32	SEC
Gain Therapeutics, Inc.Listing on record	May 23, 2022	Buy	9,256	2.83 USD	$26.2K	conv 38	SEC
Gain Therapeutics, Inc.Listing on record	May 23, 2022	Buy	4,000	2.71 USD	$10.8K	conv 35	SEC
Gain Therapeutics, Inc.Listing on record	Apr 21, 2022	Buy	4,922	7.87 USD	$38.7K	conv 46	SEC
NeuBase Therapeutics, Inc.Listing unverified	Mar 7, 2022	Buy	1,300	1.72 USD	$2.2K	conv 13	SEC
NeuBase Therapeutics, Inc.Listing unverified	Mar 7, 2022	Buy	1,000	1.62 USD	$1.6K	conv 13	SEC
NeuBase Therapeutics, Inc.Listing unverified	Mar 7, 2022	Buy	1,580	1.58 USD	$2.5K	conv 21	SEC
NeuBase Therapeutics, Inc.Listing unverified	Sep 17, 2021	AwardD (derivative)	38,135	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeuBase Therapeutics, Inc.Listing unverified	Apr 27, 2021	Buy	5,000	5.00 USD	$25K	conv 41Cluster	SEC
NeuBase Therapeutics, Inc.Listing unverified	Sep 11, 2020	AwardD (derivative)	14,634	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeuBase Therapeutics, Inc.Listing unverified	May 4, 2020	Buy	8,333	6.00 USD	$50K	conv 62ClusterFirst in 12mo	SEC
NeuBase Therapeutics, Inc.Listing unverified	May 4, 2020	Buy	2,500	6.00 USD	$15K	conv 40ClusterFirst in 12mo	SEC
ADMA BIOLOGICS, INC.Listing on record	Mar 3, 2020	Award	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADMA BIOLOGICS, INC.Listing on record	Mar 3, 2020	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeuBase Therapeutics, Inc.Listing unverified	Jul 16, 2019	Award	25,247	—	n/a (No price was disclosed in the filing)		SEC
NeuBase Therapeutics, Inc.Listing unverified	Jul 16, 2019	AwardD (derivative)	227,330	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC